As of 2024-12-15, the Relative Valuation of Atossa Therapeutics Inc (ATOS) is (3.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.12 USD, the upside of Atossa Therapeutics Inc based on Relative Valuation is -441.9%.
The range of the Relative Valuation is (2.43) - (4.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 24.1x | 17.3x |
| Forward P/E multiples | 11.3x - 18.9x | 18.5x |
| Fair Price | (2.43) - (4.03) | (3.83) |
| Upside | -316.6% - -460.2% | -441.9% |
| Date | P/E |
| 2024-12-13 | -5.24 |
| 2024-12-12 | -5.38 |
| 2024-12-11 | -5.70 |
| 2024-12-10 | -5.89 |
| 2024-12-09 | -5.84 |
| 2024-12-06 | -5.70 |
| 2024-12-05 | -5.61 |
| 2024-12-04 | -5.47 |
| 2024-12-03 | -5.75 |
| 2024-12-02 | -5.94 |
| 2024-11-29 | -6.08 |
| 2024-11-27 | -5.98 |
| 2024-11-26 | -6.03 |
| 2024-11-25 | -5.98 |
| 2024-11-22 | -5.70 |
| 2024-11-21 | -5.56 |
| 2024-11-20 | -5.61 |
| 2024-11-19 | -5.98 |
| 2024-11-18 | -5.98 |
| 2024-11-15 | -5.98 |
| 2024-11-14 | -6.40 |
| 2024-11-13 | -6.40 |
| 2024-11-12 | -7.01 |
| 2024-11-11 | -7.57 |
| 2024-11-08 | -7.01 |
| 2024-11-07 | -7.01 |
| 2024-11-06 | -6.92 |
| 2024-11-05 | -6.54 |
| 2024-11-04 | -6.59 |
| 2024-11-01 | -6.64 |
| 2024-10-31 | -6.45 |
| 2024-10-30 | -6.59 |
| 2024-10-29 | -6.68 |
| 2024-10-28 | -6.78 |
| 2024-10-25 | -6.64 |
| 2024-10-24 | -6.59 |
| 2024-10-23 | -6.83 |
| 2024-10-22 | -7.01 |
| 2024-10-21 | -6.78 |
| 2024-10-18 | -6.78 |
| 2024-10-17 | -6.78 |
| 2024-10-16 | -6.87 |
| 2024-10-15 | -6.68 |
| 2024-10-14 | -6.64 |
| 2024-10-11 | -6.73 |
| 2024-10-10 | -6.50 |
| 2024-10-09 | -6.54 |
| 2024-10-08 | -6.64 |
| 2024-10-07 | -6.64 |
| 2024-10-04 | -6.87 |